Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityOther Non-Current LiabilitiesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Inventory (2021 - 2025)

Goldenwell Biotech's Inventory history spans 5 years, with the latest figure at $174788.0 for Q3 2025.

  • For Q3 2025, Inventory changed 0.06% year-over-year to $174788.0; the TTM value through Sep 2025 reached $174788.0, changed 0.06%, while the annual FY2024 figure was $174788.0, 0.04% changed from the prior year.
  • Inventory reached $174788.0 in Q3 2025 per GWLL's latest filing, roughly flat from $174788.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $205725.0 in Q2 2021 to a low of $103125.0 in Q1 2021.
  • Average Inventory over 5 years is $177842.1, with a median of $175013.0 recorded in 2023.
  • The largest YoY upside for Inventory was 92.47% in 2022 against a maximum downside of 12.18% in 2022.
  • A 5-year view of Inventory shows it stood at $198671.0 in 2021, then decreased by 11.38% to $176058.0 in 2022, then fell by 0.68% to $174863.0 in 2023, then decreased by 0.04% to $174788.0 in 2024, then changed by 0.0% to $174788.0 in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Inventory are $174788.0 (Q3 2025), $174788.0 (Q2 2025), and $174788.0 (Q1 2025).